Danny J. Eckert

Mar 1, 2024 | openres.ersjournals.com | Robert Adams |Danny J. Eckert

IntroductionAlmost one billion people worldwide are estimated to have obstructive sleep apnoea (OSA) [1], a condition that triples the risk of cardiometabolic diseases [2], such as cardiovascular disease (CVD) [3], diabetes [4] and mortality [5]. The primary predictor of OSA is obesity, especially central obesity [6]. Effective treatment to reduce OSA severity includes lifestyle modifications, such as weight loss through exercise and diet [7, 8].